Escherichia coli: Epidemiology and analysis of risk factors for infections caused by resistant strains

Clinical Infectious Diseases

Volumn 29, Issue 3, 1999, Pages 548-552

  Lepelletier, Didier ^a   Caroff, Nathalie ^a   Reynaud, Alain ^a   Richet, Hervé ^a  

^a NANTES UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; CEFALOTIN; CEFTAZIDIME; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; NALIDIXIC ACID; NITROFURANTOIN; NORFLOXACIN; OFLOXACIN; PEFLOXACIN; TICARCILLIN; TOBRAMYCIN;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; CHILD; CONTROLLED STUDY; ENTEROBACTER INFECTION; ESCHERICHIA COLI; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR;

EID: 0032845719     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/598632     Document Type: Article

References (31)

1. Holmberg SD, Solomon SL, Blake PA. Health and economic impacts of antimicrobial resistance. Rev Infect Dis 1987;9:1065-78.
2. Haley RW. Measuring the costs of nosocomial infections: methods for estimating economic burden on the hospital. Am J Med 1991;91(suppl 3B):32S-8S.
3. Gaynes RP. Surveillance of nosocomial infections: a fundamental ingredient for quality. Infect Control Hosp Epidemiol 1997;18:475-8.
4. Jarvis WR. Preventing the emergence of multidrug-resistant microorganisms through antimicrobial use controls the complexity of the problem. Infect Control Hosp Epidemiol 1996;17:490-5.
5. Panlilio AL, Culver DH, Gaynes RP, et al. Methicillin-resistant Staphylococcus aureus in US hospitals, 1975-1991. Infect Control Hosp Epidemiol 1992;13:582-6.
6. Morris JG, Shay DK, Hebden JN, et al. Enterococci resistant to multiple antimicrobial agents, including vancomycin: establishment of endemicity in a university medical center. Ann Intern Med 1995;123:250-9.
7. Goldmann DA, Weinstein RA, Wenzel RP, et al. Strategies to prevent and control the emergence and spread of antimicrobial-resistant microorganisms in hospitals: a challenge to hospital leadership. JAMA 1996;275: 234-40.
8. Soussy CJ. Etat actuel de la résistance aux antibiotiques. Médecine Thérapeutique 1997;3(HS):24-36.
9. Soussy CJ, Duval J, Courvallin P. Résistance aux antibiotiques chez Escherichia coli: Etats actuels et nouvelles acquisitions. Med Mal Infect 1988;1:29-36.
10. Soussy CJ, Cluzel R, Courvallin P. Definition and determination of in vitro antibiotic susceptibility breakpoints for bacteria in France. The Comité de l'Antibiogramme de la Société Française de Microbiologic. Eur J Clin Microbiol Infect Dis 1994;13:238-46.
11. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988;16:128-40.
12. Atkinson BA, Lorian V. Antimicrobial agent susceptibility patterns of bacteria in hospitals from 1971 to 1982. J Clin Microbiol 1984;20: 791-6.
13. McGowan AP, Brown NM, Holt HA, Lovering AM, McCulloch SY, Reeves DS. An eight-year survey of the antimicrobial susceptibility patterns of 85,971 bacteria isolated from patients in a district general hospital and the local community. J Antimicrob Chemother 1993;31: 543-57.
14. Kresken M, Wiedemann B. Development of resistance in the past decade in central Europe. J Antimicrob Chemother 1986;18(suppl C):235-42.
15. Philippon A, Arlet G, Lagrange Ph. Escherichia coli: fréquence de résistance et évolution à divers antibiotiques urinaires dont la fosfomycine en milieu hospitalier. Med Mal Infect 1996;26:539-41.
16. Laurichesse H, Henquell C, Marcucilli A, et al. Epidémiologie des résistances d'Escherichia coli en Auvergne: d'après différentes sources. Med Mal Infect 1994;24(suppl):526-9.
17. Dublanchet A, Burnat C. Escherichia coli dans un höpital général de 1982 à 1993. Med Mal Infect 1994;24(suppl):530-4.
18. Allouch Y. Sensibilité aux bëta-lactamines de souches d'E. coli isolées en 1989 et 1993 dans 9 hôpitaux généraux. Med Mal Infect 1994;24(suppl): 521-5.
19. Delarbre JM, Grasmick CP, Coumenges P, et al. Sensibilité aux antibiotiques de Escherichia coli isolé d'hémoculture et d'examens cytobactériologique des urines réalisés dans 15 hôpitaux généraux du Sud-Ouest de la France. Med Mal Infect 1994;24(suppl):535-8.
20. Allouch PY, Labia R, Pina P, Morin E. Observatoires hospitaliers de la sensibilité de Escherichia coli et de Klebsiella à l'association amoxicilline-acide clavulanique en 1994. Med Mal Infect 1995;25: 934-9.
21. Nguyen Van JC, Collet L, Chardon H, et al. Etude de la sensibilité à l'Augmentin de souches de Escherichia coli isolées en 1992 dans quatre centres hospitaliers français (Etude COLICERIB I). Med Mal Infect 1994;24:765-73.
22. Mc Gowan JE Jr. Is antimicrobial resistance in hospital microorganisms related to antibiotic use? Bull NY Acad Med 1987;63:253-68.
23. Mc Gowan JE Jr. Do intensive hospital antibiotic control programs prevent the spread of antibiotic resistance? Infect Control Hosp Epidemiol 1994;15:478-83.
24. Richard P, Delangle MH, Merrien D, et al. Fluoroquinolone use and fluoroquinolone resistance: is there an association? Clin Infect Dis 1994;19:54-9.
25. Kresken M, Wiedemann B. Development of resistance to nalidixic acid and the fluoroquinolones after the introduction of norfloxacin and ofloxacin. Antimicrob Agents Chemother 1988;32:1285-8.
26. Muder RR, Brenner C, Goetz AM, Wagener MM, Rihs JD. Association with prior fluoroquinolone therapy of widespread ciprofloxacin resistance among gram-negative isolates in a Veterans Affairs Medical Center. Antimicrob Agents Chemother 1991;35:256-8.
27. Pena C, Albareda JM, Pallares R, Pujol M, Tubau F, Ariza J. Relationship between quinolone use and emergence of ciprofloxacin-resistant Escherichia coli in bloodstream infections. Antimicrob Agents Chemother 1995;39:520-4.
28. Murray BE, Rensimer ER, Dupont HL. Emergence of high-level trimethoprim resistance in fecal Escherichia coli during oral administration of trimethoprim or trimethoprim-sulfamethoxazole. N Engl J Med 1982;306:130-5.
29. Natsch S, Conrad C, Hartmeier C, Schmid B. Use of amoxicillin-clavulanate and resistance in Escherichia coli over a 4-year period. Infect Control Hosp Epidemiol 1998;19:653-6.
30. Datta N, Faiers MC, Reeves DS, Brumfitt W, Orskov F, Orskov I. Risk factors in Escherichia coli in faeces after oral chemotherapy in general practice. Lancet 1971;13:141-6.
31. Finland M. Emergence of antibiotic resistance in hospitals, 1935-1975. Rev Infect Dis 1979;1:4-21.